InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Reilly Dennis, Chief Financial Officer. Director active across 1 company, notably Agile Therapeutics INC. Aggregated, 6 filings have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €136k. History available since 11 May 2021. The latest transaction was filed on 27 July 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
58,824 sharesCommon StockSEC:0001104659-21-126014:0
Ideal exit: 10 Jul 2022 (T+270)
58,824 sharesCommon StockSEC:0001104659-21-126014
Ideal exit: 10 Jul 2022 (T+270)
50,000 shares@ US$1.082933.7% of flowCommon StockSEC:0001104659-21-097152
Ideal exit: 23 Apr 2022 (T+270)
50,000 shares@ US$1.082933.7% of flowCommon StockSEC:0001104659-21-097152:0
Ideal exit: 23 Apr 2022 (T+270)
20,000 shares@ US$1.3516.3% of flowCommon StockSEC:0001104659-21-065161
Ideal exit: 5 Feb 2022 (T+270)
20,000 shares@ US$1.3516.3% of flowCommon StockSEC:0001104659-21-065161:0
Ideal exit: 5 Feb 2022 (T+270)
6 of 6 declarations
About Reilly Dennis
Dennis Reilly is the Chief Financial Officer at Agile Therapeutics Inc. He oversees financial management, budgeting, and investment strategy for the company. Dennis plays a key role in optimizing financial performance and regulatory compliance.
